PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET

Abstract: the pharmacoeconomic study compared the standard drug therapy (vitamin D and phosphorbinders) of secondary hyperparathyroidism (SHPT) to the using a combination of Mimpara (Cinalcet), vitamin D and phosphorbinders in patients with end-stage renal disease on dialysis. Comparison was carried...

Full description

Bibliographic Details
Main Authors:	R. I. Yagudina, V. G. Serpik
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-03-01
Series:	Фармакоэкономика
Subjects:	pharmacoceconomic analysis «cost-efficacy» analysis secondary hyperparathyroidism cinacalcet mimpara
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/39

Similar Items

The treatment of secondary hyperparathyroidism in haemodialysis patients' refractory to alfacalcidol
by: L V Egshatyan, et al.
Published: (2012-06-01)

Changes of Serum Total and Free Testosterone Concentrations in Male Chronic Hemodialysis Patients with Secondary Hyperparathyroidism in Response to Cinacalcet Treatment
by: Piotr Kuczera, et al.
Published: (2016-01-01)

Efficacy of low-dose cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: a single-center study
by: Gojaseni P, et al.
Published: (2017-02-01)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019-06-01)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
by: Jeong S, et al.
Published: (2016-07-01)

Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis
by: Zhuolin Zhang, et al.
Published: (2021-07-01)

Cinacalcet and primary hyperparathyroidism: systematic review and meta regression
by: Cheng Han Ng, et al.
Published: (2020-08-01)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
by: Paweena Susantitaphong, et al.
Published: (2019-01-01)

Diameter of Parathyroid Glands Measured by Computed Tomography as a Predictive Indicator for Response to Cinacalcet in Dialysis Patients with Secondary Hyperparathyroidism
by: Yu Ah Hong, et al.
Published: (2015-05-01)

Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
by: Yuka Kurokawa, et al.
Published: (2020-12-01)

Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
by: Soliman Amin R., et al.
Published: (2016-09-01)

Comparison between Calcitriol and Calcitriol Plus Low-Dose Cinacalcet for the Treatment of Moderate to Severe Secondary Hyperparathyroidism in Chronic Dialysis Patients
by: Chien-Te Lee, et al.
Published: (2013-04-01)

Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
by: H.K. Aggarwal, et al.
Published: (2013-09-01)

Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
by: Irene Ruderman, et al.
Published: (2018-05-01)

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
by: Keiichi Otsuka, et al.
Published: (2018-10-01)

A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic
by: Yuichiro Ohya, et al.
Published: (2018-05-01)

Cinacalcet versus parathyroidectomy for primary hyperparathyroidism: a single centre experienc
by: Salvatore Giovinazzo, et al.
Published: (2019-11-01)

Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
by: Jacek Zawierucha, et al.
Published: (2019-02-01)

Primary Hyperparathyroidism-A Review of this Disorder and an Interesting Case Treated with Cinacalcet
by: Abdul Rafi Mohammed, et al.
Published: (2009-06-01)

Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysis
by: Yiting Sun, et al.
Published: (2020-07-01)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
by: Giulia Di Dalmazi, et al.
Published: (2018-12-01)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
by: Alessandro Roggeri, et al.
Published: (2020-03-01)

Effects of preoperative cinacalcet hydrochloride treatment on the operative course of parathyroidectomy and pathological changes in resected parathyroid glands
by: Akiko Takeshima, et al.
Published: (2017-10-01)

Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure
by: José M. Orellana, et al.
Published: (2016-03-01)

Secondary and tertiary hyperparathyroidism in chronic kidney disease
by: Lilit V. Egshatyan, et al.
Published: (2017-12-01)

Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism
by: Francisco José Borrego Utiel, et al.
Published: (2015-07-01)

The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report
by: Daisuke Takada, et al.
Published: (2017-10-01)

Successful treatment of early allograft dysfunction with cinacalcet in a patient with nephrocalcinosis caused by severe hyperparathyroidism: a case report
by: Boonyarit Cheunsuchon, et al.
Published: (2017-04-01)

PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET
by: L. V. Egshatyan, et al.
Published: (2015-09-01)

Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”
by: Domenico Russo, et al.
Published: (2019-07-01)

Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study
by: Simone Brardi, et al.
Published: (2015-03-01)

A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
by: Helen Eddington, et al.
Published: (2021-03-01)

Primary Hyperparathyroidism in Pregnancy: Literature Review of the Diagnosis and Management
by: Dalal S. Ali, et al.
Published: (2021-06-01)

A novel calcimimetic evocalcet for the management of secondary hyperparathyroidism with little effect on the gastrointestinal tract and cyp isozymes in vivo and in vitro
by: Lilit V. Egshatyan
Published: (2020-06-01)

Use of Cinacalcet in the treatment of persistent hyperparathyroidism post-renal transplant. A single center experience in Argentina
by: Jorge Camacho, et al.
Published: (2017-06-01)

Cinacalcet therapy and cardiovascular risk in hemodialysis patients
by: Marzena Żelaźnicka, et al.
Published: (2012-10-01)

Multi-Modal Treatment Of Calciphylaxis With Sodium-Thiosulfate, Cinacalcet And Sevelamer Including Long-Term Data
by: Hermann Salmhofer, et al.
Published: (2013-09-01)

Experience of surgical treatment of secondary hyperparathyroidism
by: E. A. Ilyicheva, et al.
Published: (2016-07-01)

Calciphylaxie, insuffisance rénale, cinacalcet
by: Fatima-Zahra Agharbi
Published: (2020-02-01)

Surgical Management of Secondary Hyperparathyroidism
by: Gabrielle K. Steinl, et al.
Published: (2021-02-01)